| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $27,4200 | +3,43% | $1,74B | $389,15K | |
SGRY Surgery Partners, Inc. Common Stock | $13,5650 | -1,49% | $1,74B | $904,63K | |
GAB The Gabelli Equity Trust Inc. | $5,6050 | -0,27% | $1,74B | $689,96K | |
HURN Huron Consulting Group Inc. | $104,88 | -1,62% | $1,74B | $135,27K | |
ENVX Enovix Corporation Common Stock | $8,2210 | -4,63% | $1,74B | $5,50M | |
PAYO Payoneer Global Inc. Common Stock | $5,0350 | -5,89% | $1,74B | $3,33M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9200 | -0,20% | $1,73B | $152,89K | |
STGW Stagwell Inc. Class A Common Stock | $6,5850 | -8,54% | $1,73B | $1,37M | |
CASH Pathward Financial, Inc. Common Stock | $78,2550 | -3,88% | $1,73B | $203,18K | |
SNDX Syndax Pharmaceuticals, Inc. | $18,4050 | +0,08% | $1,73B | $660,71K | |
STRA Strategic Education, Inc. Common Stock | $78,7180 | -0,56% | $1,73B | $108,71K | |
CAPR Capricor Therapeutics Inc | $27,3890 | +0,18% | $1,73B | $456,67K | |
AAPG Ascentage Pharma Group International American Depository Shares | $17,8250 | -3,39% | $1,73B | $20,68K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,1600 | -2,04% | $1,73B | $6,50M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $24,9050 | +2,57% | $1,73B | $199,31K | |
